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Abstract
Binding of allergen-speciﬁc IgE to its primary receptor FcεRI on basophils and mast cells represents a central event in
the development of allergic diseases. The high-afﬁnity interaction between IgE and FcεRI results in permanent
sensitization of these allergic effector cells and critically regulates their release of pro-inﬂammatory mediators upon IgE
cross-linking by allergens. In addition, binding of monomeric IgE has been reported to actively regulate FcεRI surface
levels and promote survival of mast cells in the absence of allergen through the induction of autocrine cytokine
secretion including interleukin-3 (IL-3). As basophils and mast cells share many biological commonalities we sought to
assess the role of monomeric IgE binding and IL-3 signaling in FcεRI regulation and cell survival of primary human
basophils. FcεRI cell surface levels and survival of isolated blood basophils were assessed upon addition of monomeric
IgE or physiologic removal of endogenous cell-bound IgE with a disruptive IgE inhibitor by ﬂow cytometry. We further
determined basophil cell numbers in both low and high serum IgE blood donors and mice that are either sufﬁcient or
deﬁcient for FcεRI. Ultimately, we investigated the effect of IL-3 on basophil surface FcεRI levels by protein and gene
expression analysis. Surface levels of FcεRI were passively stabilized but not actively upregulated in the presence of
monomeric IgE. In contrast to previous observations with mast cells, monomeric IgE binding did not enhance basophil
survival. Interestingly, we found that IL-3 transcriptionally regulates surface levels of FcεRI in human primary basophils.
Our data suggest that IL-3 but not monomeric IgE regulates FcεRI expression and cell survival in primary human
basophils. Thus, blocking of IL-3 signaling in allergic effector cells might represent an interesting approach to diminish
surface FcεRI levels and to prevent prolonged cell survival in allergic inﬂammation.
Introduction
Binding of allergen-speciﬁc immunoglobulin E (IgE) to its
high-afﬁnity receptor FcεRI expressed on basophils and
mast cells is a central step in the induction of allergic
hypersensitivity reactions1. On these cells, FcεRI is expres-
sed as a hetero-tetramer2. IgE binding occurs asymme-
trically via two binding sites in the extracellular part of the
FcεRI α-subunit (FcεRIα)3. The membrane tetra-spanning
β-chain (FcεRIβ), and the two identical disulﬁde-linked γ-
chains (FcεRIγ) are not involved in the IgE interaction but
are essential for receptor maturation, receptor surface
transport, and the propagation of FcεRI-mediated signaling
pathways4. Owing to the high-afﬁnity interaction of IgE:
FcεRI complexes basophils and mast cells are permanently
sensitized with IgE and are thus ready to immediately
respond to allergen challenge. Antigen-induced co-aggre-
gation of receptor-bound IgE stimulates the release of pre-
stored and de novo synthesized mediators that induce
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classical allergy symptoms including bronchoconstriction,
vasodilatation, and increased mucus production5.
In 1978, researchers have observed that serum IgE levels
of atopic as well as non-atopic subjects positively correlate
with surface FcεRI levels on primary human basophils6.
These ﬁndings have sparked the hypothesis that IgE might
be involved in the regulation of FcεRI expression on
allergic effector cells. More recently, in vivo studies using
the therapeutic monoclonal anti-IgE antibody omalizu-
mab have conﬁrmed that reducing serum IgE level in
atopic patients goes along with decreased FcεRI levels on
human basophils and mast cells7–9. In addition, various
studies reported that monomeric IgE is directly involved
in the regulation of surface FcεRI expression in murine
bone marrow-derived mast cells and human umbilical
cord blood-derived mast cells10–13. Binding of monomeric
IgE to FcεRI has furthermore been described to promote
survival of mBMMC in the absence of allergen14–17.
Interestingly, the mechanisms underlying IgE-mediated
cell survival suggested in these studies greatly differed.
Although one study attributed prolonged mBMMC sur-
vival to the induction of autocrine cytokine secretion and
elevated expression of the antiapoptotic Bcl-2 family
member Bcl-XL
15, the other study speciﬁcally excluded
both of these possibilities14. Subsequent investigations
have suggested that particularly the induction of auto-
crine interleukin-3 (IL-3) secretion is responsible for the
enhanced mast cell survival upon monomeric IgE
binding18. How the monomeric interaction between IgE
and FcεRI can induce intracellular signaling cascades in
mast cells remained obscure until it was found that
there are so-called highly cytokinergic (HC) IgE
clones19,20. Most of these HC IgE clones exhibit poly-
reactivity to autoantigens or display self-reactivity21–23.
They may therefore induce FcεRI aggregation in the
absence of allergen, which could lead to the induction of
cytokine production including IL-324. For basophils and
mast cells, IL-3 is a well-characterized proliferation and
survival factor25–27. Thus, the enhanced survival that
has initially been attributed to monomeric IgE binding
might be owing to IgE aggregation on the cell surface in
the absence of allergen. Whether HC IgE is present
in vivo and if it has a role in the regulation of mast cell
survival remains elusive.
Despite controversial ﬁndings with mast cells, we aimed
to investigate the effect of monomeric IgE binding and IL-
3 signaling on FcεRI regulation and cell survival of human
primary blood basophils in this study. We have recently
generated a novel disruptive anti-IgE DARPin® protein
(bi53_79)28–30, that we used as a tool to actively remove
IgE from the cell surface under physiological conditions.
Our results demonstrate that removal of IgE leads to loss
of FcεRI on the cell surface, whereas FcεRI-bound IgE
stabilizes receptor levels. However, the presence and
amount of monomeric IgE did not inﬂuence the survival
of in vitro cultured primary human basophils or change
the number of measured blood basophil numbers in vivo.
Further, our results provide strong evidence that IL-3
signaling but not monomeric IgE binding regulates FcεRI
levels on the basophil cell surface.
Results
IgE stablilizes FcεRI on human primary basophils
To investigate the effect of IgE on the surface
expression of FcεRI we isolated primary human blood
basophils from donors with low ( ≤ 32 kU/L) and high
serum IgE levels ( > 32 kU/L). Basophils were either
incubated with medium, exogenous recombinant
human IgE, bi53_79 to remove endogenous IgE or with
bi53_79 prior to the addition of exogenous recombinant
human IgE. The FcεRI and IgE cell surface levels were
determined over a period of 7 days. Compared with
incubation in medium the addition of exogenous IgE
reduced the loss of FcεRI on basophils from both low
(Fig. 1a) and high serum IgE (Fig. 1b) donors. In line
with this observation, the removal of endogenous IgE
with bi53_79 resulted in an accelerated loss of FcεRI in
both groups. Stripping and subsequent reloading with
exogenous IgE also led to a reduction in receptor loss.
Basophils from low IgE donors treated with exogenous
IgE showed slightly increased IgE surface levels (Fig. 1c),
whereas those on basophils from high serum IgE-
remained stable (Fig. 1d). In agreement with previous
studies31, these experiments demonstrate that the
addition of monomeric IgE reduces the loss FcεRI on
basophils from both low and high serum IgE level
donors.
Monomeric IgE binding does not inﬂuence survival of
human blood basophils
We next assessed whether IgE binding might enhance
survival of primary human basophils as previously
described for mast cells14,15. For this purpose, we
compared the ex vivo survival of isolated human baso-
phils and assessed the effect of IgE removal with bi53_79
versus addition of exogenous IgE. Surprisingly, we did
not observe a difference in cell survival over the period
of 72 h (Fig. 2a,b). Neither endogenous cell-bound IgE
nor experimental removal or addition of recombinant
IgE had a signiﬁcant effect on cell viability ex vivo. Along
this line, we could not observe a difference in survival
between basophils isolated from low or high serum IgE
donors after 72 h of culture (Fig. 2c–f). In addition, we
performed western blot analysis with basophils of three
donors to further assess intracellular pro- and anti-
apoptotic signaling pathways on a molecular level. In
line with the cell viability data measured by ﬂow cyto-
metry we did not observe any signiﬁcant difference in
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pro-apoptotic caspase-3 cleavage nor an induction of
antiapoptotic molecule Bcl-2 upon addition of mono-
meric IgE (Fig. 2g). As a control, we generated bone
marrow-derived mast cells (BMMCs) from mice that
lack murine FcεRIα but transgenically express func-
tional human FcεRIα (huFcεRIαtg)32. Addition of mur-
ine IL-3 but not monomeric IgE prolonged the survival
of these cells as assessed by ﬂow cytometry and western
blot (Fig. S1). These data strongly indicate that the
monomeric IgE clones used in this study do not enhance
the survival of human primary basophils or BMMCs
from huFcεRIαtg mice ex vivo.
IgE levels in humans or lack of FcεRIα in mice does not
alter blood basophil counts
To assess whether the presence of high IgE levels reg-
ulates circulating basophil numbers in vivo we quantiﬁed
blood basophil numbers of human individuals with low
( ≤ 32 kU/L) or high ( > 32 kU/L) IgE serum levels by ﬂow
cytometry. There was no signiﬁcant difference in the
blood basophil counts between these two groups (Fig. 3a).
In addition, we did not ﬁnd any correlation of IgE serum
levels with blood basophil counts (Fig. 3b). To investigate
whether FcεRI signaling is involved in the survival of
murine basophils in vivo we quantiﬁed blood basophil
Fig. 2 Survival of primary human basophils in the presence or absence of monomeric IgE. Isolated primary human basophils from low ( ≤ 32
kU/L) and high ( > 32 kU/L) serum IgE donors were analyzed for cell viability over a 72-hour time period. a and b Cells were incubated either in
medium alone, with exogenous recombinant human IgE (100 nM), with the disruptive anti-IgE DARPin® protein bi53_79 (5 µM) or with the disruptive
anti-IgE DARPin® protein bi53_79 and exogenous recombinant human Sus11-IgE in combination. Comparison of cell viability between basophils
from low and high serum IgE blood donors at 72 h incubation in medium c, IgE d, bi53_79 e or bi53_79 and IgE f. A comparative western blot
analysis of pro- (i.e., cleaved caspase-3) and antiapoptotic proteins (i.e. BCL-2) in primary human basophils from three blood donors that were
cultured for 0, 24 and 72 h in medium, IgE, bi53_79 or bi53_79 and IgE g. GAPDH serves as loading control. Statistical signiﬁcance was calculated by
Student’s t-test at 72 h and data are shown as mean ± SEM, n= 5
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numbers in mice lacking the murine FcεRIα but that are
transgenic for the human FcεRIα (huFcεRIαtg) by ﬂow
cytometry. These cell numbers were compared to the
basophil counts of littermates lacking both the murine
and the human FcεRIα (huFcεRIα−/−) (Fig. 3c,d). As an
additional reference, we also included wildtype C57BL/6
(WT). It is known that murine IgE has the ability to bind
to human FcεRIα33 and that human FcεRIα signaling is
functional in huFcεRIαtg mice32. In addition to our
observation that monomeric IgE did not affect survival of
human blood basophils ex vivo, we did not detect any
changes in blood basophil numbers between huFcεRIαtg
and huFcεRIα−/− mice (Fig. 3e). The increased basophil
counts that could be observed between WT and trans-
genic mice is likely owing to differences in the genetic
background. Our ﬁnding that the lack of FcεRIα does not
affect absolute basophil numbers in mice is in line with
previous ﬁndings that show no difference in survival of
basophils from wildtype and IgE knockout mice34.
IL-3 increases FcεRI levels on human basophils
IL-3 is a well-characterized pro-survival cytokine for
primary human basophils, which is commonly used to
extend their viability ex vivo27. As we did not observe an
active upregulation of FcεRI levels on basophils by
monomeric IgE, we asked whether IL-3 might be involved
Fig. 3 In vivo basophil counts in human low and high serum IgE donors and mice that are sufﬁcient or deﬁcient for FcεRI. Comparison of
basophil cell counts in blood from low ( ≤ 32 kU/L, n= 6, gray bars) versus high ( > 32 kU/L, n= 9, black bars) serum IgE donors a. b Correlation
between blood basophil cell counts and total serum IgE in different blood donors (n= 15). c Representative ﬂow cytometry measurement of CD49+/
CD200R3+ blood basophils in wildtype, huFcεRIαtg and huFcεRIα−/− mice. d Isotype staining control for CD49b. e Absolute quantiﬁcation of blood
basophil cell counts in wildtype (n= 6), huFcεRIαtg (n= 4), and huFcεRIα−/− (n= 8) mice. Data are shown as mean values ± SEM
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in receptor regulation. Thus, we performed cell culture
assays with isolated primary human basophils in the
presence or absence of recombinant human IL-3. Upon
incubation of the cells with IL-3 we detected a time-and
dose-dependent increase of FcεRI receptor levels by ﬂow
cytometry (Fig. 4a,b). Other cytokines that signal through
the same receptor family on primary human basophils,
such as IL-5 and granulocyte–macrophage colony-
stimulating factor (GM-CSF), did not induce changes in
FcεRI surface levels (Fig. 4c). These data indicate that
FcεRI levels are speciﬁcally regulated through IL-3
receptor signaling. Interestingly, IL-3 mediated upregu-
lation of surface FcεRI showed a strong correlation to the
initial donor-speciﬁc receptor level (Fig. 4d). In other
words, donors with high initial FcεRI levels displayed an
increased accumulation of new receptor compared with
donors with low initial FcεRI levels. To gain further
insight into this IL-3-dependent mechanism of receptor
regulation we performed gene expression analysis. Iso-
lated primary blood basophils were incubated in medium
or medium containing IL-3 for 4 or 18 h. Basophil RNA
was extracted and subsequently used for whole-genome
expression measurements. Surprisingly, bioinformatic
analysis revealed that transcription of FCERIA is slightly
downregulated upon incubation of the cells with IL-3.
However, MS4A2 the gene encoding the FcεRIβ was
Fig. 4 IL-3-mediated increase of surface FcεRI levels. Isolated primary human basophils were incubated for 24 h with medium, IL-3 (10 ng/ml),
Sus11-IgE (100 nM) or IL-3 and IgE in combination a, different concentrations of IL-3 (0.1−10 ng/ml) b, IL-3 (10 ng/ml), GM-CSF (10 ng/ml) or IL-5 (10
ng/ml) c. FcεRI surface levels were determined by ﬂow cytometry and the percentage change compared to initial geometric mean ﬂuorescence
intensities are shown. The correlation between the initial FcεRI level with the FcεRI level after 24-hour incubation with IL-3 (10 ng/ml) on the surface
of basophils isolated from different donors (n= 10) is displayed d. FcεRI levels on the surface of isolated basophils from different donors (n= 10) after
24-hour incubation with either medium or IL-3 (10 ng/ml) are compared e. Normalized and log2-transformed gene expression results for FCERIA
(FcεRIα), MS4A2 (FcεRIβ), and FCERIG (FcεRIγ) are shown from two independent arrays using pooled basophil RNA of three individual donors after
incubation with medium or IL-3 for 4 or 18 h f. The relative log2 fold change (RLFC) of IL-3-treated basophils is shown as a heat-map for the indicated
genes g. Data are shown as mean values ± SEM
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Fig. 5 (See legend on next page.)
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highly upregulated after 18 h in presence of IL-3 (Fig. 4f,
g). Other genes including GZMB35, TNFSF1136, ENPP337,
FCGR2A, and FCGR2B38 are known to be tran-
scriptionally upregulated by IL-3 and are shown as con-
trols. It has previously been reported that FcεRIβ is an
ampliﬁer of FcεRI cell surface expression2,39,40. It does so
by promoting maturation and trafﬁcking of the associated
FcεRIα. In addition, FcεRIβ might stabilize the cell surface
expressed FcεRI complex. We also found a moderate
transcriptional upregulation of FCERIG, the gene encod-
ing the FcεRIγ upon IL-3 incubation. Previous studies
have demonstrated that cells lacking FcεRIγ transcripts do
not express surface FcεRI. Taken together our data sug-
gest that the IL-3-mediated increase in FcεRI levels on
primary human basophils is owing to transcriptional
upregulation of FcεRIβ and FcεRIγ but not FcεRIα.
IL-3 induced FcεRI binds IgE and is functionally active
Next, we assessed whether IL-3-induced FcεRI binds IgE
and whether it is functional in terms of IgE-dependent
antigen stimulation. To determine whether the newly dis-
played receptor is capable of binding IgE, isolated primary
human basophils were cultured in the presence or absence
of IL-3 for 18 h and subsequently incubated with recom-
binant human IgE. Basophils of all donors showed increased
IgE levels in the presence of IL-3 as assessed by ﬂow
cytometry (Fig. 5a,b). To investigate the functionality of the
newly displayed receptor we used recombinant 4-Hydroxy-
3-iodo-5-nitrophenylacetyl (NIP)-speciﬁc human IgE in
these basophil cultures. Subsequent stimulation with NIP-
(7)-BSA antigen resulted in a dose-dependent activation
exclusively of those cells that were incubated in IL-3 and
NIP-speciﬁc human IgE (Fig. 5c,d). In the absence of IL-3,
where no FcεRI increase occurs, basophils could not be
activated upon antigen challenge. These results demon-
strate that IL-3-induced FcεRI on the surface of primary
human basophils is functional and that IL-3 signaling under
inﬂammatory conditions may increase basophil sensitivity
and reactivity.
Discussion
In this study, we have evaluated the effect of monomeric
IgE and IL-3 on FcεRI regulation and cell survival in
primary human basophils. To carefully dissect the role of
IgE in this context, we took advantage of the disruptive
anti-IgE DARPin® protein bi53_79, which removes
endogenous receptor-bound IgE from the basophil cell
surface under physiological conditions. Also, we addi-
tionally separated basophil donors into two groups based
on their total serum IgE levels. Overall, basophils isolated
from high serum IgE donors showed signiﬁcantly higher
levels FcεRI on their cell surface, conﬁrming previous
ﬁndings that the surface expression of this receptor cor-
relates with soluble IgE levels in the blood6. Surface levels
of FcεRI decreased under culture conditions in which no
additional exogenous IgE was present in a time-
dependent manner. The loss of receptor was reﬂected in
the loss of surface IgE and is likely owing to the slow but
steady dissociation of IgE from the receptor under these
culture conditions. Addition of exogenous IgE decreased
the receptor loss in basophils of high serum IgE donors
and stabilized FcεRI levels in basophils of low serum IgE
donors. These data provide compelling evidence, that the
rate of receptor loss is higher than the rate of constitutive
new receptor production in basophils from high serum
IgE donors. On the other hand, this indicates that the rate
of new receptor production is equal to the rate of receptor
loss in basophils from low serum IgE donors. The dis-
crepancy between the increased IgE and unaltered FcεRI
levels on the surface of basophils from low serum IgE
donors that were incubated with exogenous IgE is most
likely owing to the fact that the anti-FcεRI-staining anti-
body used in this experiment shows minor steric overlap
with IgE binding sites (data not shown). Collectively, our
ﬁndings support the notion that IgE does not directly
regulate FcεRI expression but rather prevents FcεRI
internalization by stabilizing it through binding on the cell
surface31. The exact molecular mechanism of receptor
stabilization, however, is still unknown and needs further
investigation.
Interestingly, we identiﬁed IL-3 as a new transcriptional
regulator of FcεRI expression on human primary baso-
phils. Incubation of basophils with IL-3 resulted in a rapid
accumulation of surface IgE receptor within 24 h. The
receptor increase was associated with a transcriptional
upregulation of FcεRIβ, which has previously been
(see ﬁgure on previous page)
Fig. 5 IL-3 induced FcεRI on human basophils is functionally active. Isolated primary human basophils were incubated with medium or IL-3 (10
ng/ml) overnight and sensitized with recombinant monomeric human NIP-speciﬁc JW8-IgE (100 nM) for 30 minutes. Surface IgE levels were
determined by ﬂow cytometry. a A representative histogram indicating the increase in ﬂuorescence intensity (FI) upon incubation of IL-3 primed cells
with IgE is shown. IgE levels on the surface of isolated basophils from different donors (n= 10) after overnight incubation with medium or IL-3 (10
ng/ml) and subsequent addition of IgE (100 nM) are compared b. IL-3 primed JW8-IgE-sensitized basophils were stimulated with increasing
concentrations of NIP-7-BSA antigen. Activation was determined by measuring CD63 surface expression using ﬂow cytometry. Representative dot
plots are shown c. Quantiﬁcation of antigen-challenged basophils from different donors that were incubated with or without IL-3 overnight and
sensitized with or without JW8-IgE for 30 minutes (n= 3). Data are shown as mean values ± SEM
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described to promote the maturation and surface trans-
port of hetero-tetrameric FcεRI complexes2,39,40. We
further detected a moderate increase of FcεRIγ expres-
sion. Surprisingly, the transcription levels for FcεRIα upon
IL-3 incubation decreased, emphasizing the pivotal role of
the β- and γ-chain in FcεRI surface expression on allergic
effector cells. Nevertheless, it is important to note that of
all FcεRI subunits the α-chain showed the highest baseline
expression of transcripts. Thus, our ﬁndings support
previous data reporting that pre-synthesized FcεRIα can
be stored intracellularly in the endoplasmatic reticulum
until it associates with the homodimeric FcεRIγ alone
or the FcεRIβ together with the homodimeric FcεRIγ to
be transported to the cell surface via the Golgi
compartment2,41.
In contrast to various studies using mast cells14,15,17 we
did not observe any pro-survival effect of monomeric IgE
binding on primary human basophils. Furthermore, there
was no difference in blood basophil counts between low
and high serum IgE donors. Nevertheless, it has pre-
viously been reported that pathologically high levels of IgE
correlate with increased numbers of circulating basophils
in patients with hyperimmunoglobulinemia E syndrome
or in germ-free mice34. However, as suggested in their
study the accumulation of basophils is due to an IgE-
mediated upregulation of the IL-3 receptor on basophil
progenitor cells in the bone marrow, which leads to
increased proliferation and differentiation of the cells.
Here, we focused on fully differentiated peripheral baso-
phils, for which we could not detect any correlation
between donor serum IgE levels and cell surface IL-3
receptor expression (data not shown).
Taken together, our data provide strong evidence that
IL-3 signaling but not monomeric IgE-binding regulates
FcεRI levels and cell survival of primary human basophils.
As IL-3-mediated receptor upregulation correlated with
initial FcεRI levels of the individual donors, we assume
that genetic and environmental factors during basophil
hematopoiesis have an additional role in the regulation of
FcεRI surface levels. Overall our data suggest that targeted
blocking of IL-3 signaling on human blood basophils
might represent a promising strategy to prevent or treat
allergic inﬂammation.
Materials and Methods
Human samples and animals
Human primary basophils were isolated from whole
blood of allergic and healthy volunteers with approval
from the local ethics committee. Informed consent was
obtained from all donors in accordance with the Helsinki
Declaration. huFcεRIαtg and huFcεRIα−/− on a mixed
C57BL/6 J - C57BL/6 N background were obtained from
Prof J.-P. Kinet32. Wildtype mice on a C57BL/6 J back-
ground were purchased from Janvier Labs (Saint-
Berthevin Cedex, France). All animal experimentation was
approved from cantonal committee on animal experi-
mentation (BE48/15).
Reagents
Human Sus11-IgE (NBS-C BioScience, Vienna Austria)
and NIP-speciﬁc human JW8-IgE (NBS-C BioScience,
Vienna Austria) were used. Both IgE clones are mono-
meric as assessed by the provider (Fig. S2). Recombinant
human and murine IL-3 was purchased from Peprotech
(London, UK). Experiments on FcεRI upregulation were
performed with IL-5 (R&D Systems, Minneapolis, MN,
USA) and GM-CSF (Sandoz, Basel, Switzerland). IgE and
FcεRI surface levels were monitored with monoclonal
mouse antibodies anti-IgE (clone IgE21) and anti-FcεRIα
(clone AER-37), purchased from eBioscience (Santa Clara,
USA). IL-3 (CD123) receptor and CCR3 (CD193) were
detected with anti-CD123α (clone 9F5, BD Biosciences
Pharmingen, San Diego, CA, USA) and anti-CCR3 (clone
5E8, BD Biosciences Pharmingen, San Diego, CA, USA)
antibodies. The following antibodies were used for wes-
tern blot experiments: anti-Caspase-3 (Cell Signaling
Technology, Cambridge, UK), anti-Bcl-2 (DakoCytoma-
tion, Glostrup, DK), anti-GAPDH (Merck Millipore,
Billerica, USA) and anti-β-actin (AC-15, Sigma-Aldrich,
St. Louis, USA). Secondary HRP-labeled goat anti-rabbit
and goat anti-mouse antibodies were purchased from Bio-
Rad (Hercules, USA). Immunoreactive bands were
visualized by enhanced chemiluminescence ECL-Kit (GE
Healthcare, Chalfont St Giles, UK). Total IgE levels of
volunteering blood donors were determined by Immu-
noCAP measurement (Phadia AB, Uppsala, Sweden).
Basophil survival was measured with Propidium iodide
(100 μg/ml) purchased from Milteny Biotec GmbH (Ber-
gisch Gladbach, Germany) and Annexin V from Biole-
gend (San Diego, USA). Basophil activation upon antigen
challenge was determined using the FlowCAST kit from
Bühlmann Laboratories AG (Schoenenbuch, Switzerland).
The disruptive anti-IgE DARPin® protein bi53_79 was
previously characterized29. DARPin molecules were
expressed in E.coli and puriﬁed from cell lysates with
metal-afﬁnity chromatography according to the manu-
facturer’s manual (TALONTM Metal Afﬁnity Resins User
Manual, Clontech, CA). The proteins were further pur-
iﬁed by size exclusion chromatography with a HiLoadTM
26/60 Superdex-75 prep grade column (GE Healthcare,
Chalfont St. Giles, UK).
Basophil isolation and culture
The threshold of 32 kU/L serum IgE to separate
between low and high serum IgE donors was chosen
arbitrarily. Human primary basophils were isolated from
whole blood as previously described35. Dextran-
sedimented supernatants from voluntary blood donors
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were used for Percoll density centrifugation and puriﬁed
with basophil isolation kit II (Miltenyi Biotec, Bergisch
Gladbach, Germany). Purity of the cells was assessed by
ﬂow cytometry using anti-CD123 and anti-CD193 anti-
bodies. Flow cytometry data were analyzed with FlowJo
(TreeStar Inc., USA). Puriﬁed basophils were cultured in
96-well U-bottom plates in complete Roswell Park
Memorial Institute medium (RPMI 1640 with 10% heat-
inactivated FCS, 10 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES), 100 μg/ml streptomy-
cin, and 100 U/ml penicillin) at 37 °C, 5% CO2.
Basophil desensitization and receptor kinetics
For desensitization experiments, 2.5–5 × 104 isolated
human primary basophils from low ( ≤ 32 kU/L) and
high serum IgE donors ( > 32 kU/L) were incubated in
complete RPMI medium and IgE was removed by
incubation with 5 μM bi53_79 overnight. Cells were
washed 3 × times with 200 μl PBS to remove dissociated
IgE and DARPin® proteins from the supernatant. 50 µl
RPMI containing 10 ng/ml IL-3 was used to culture the
cells. IgE resensitization and IgE saturation was achieved
upon addition of 100 nM human Sus11-IgE for at least
60 minutes. Surface levels of IgE and FcεRI were mea-
sured every 24 h using anti-IgE and anti-FcεRI anti-
bodies by ﬂow cytometry.
Basophil survival
In total, 2.5–5 × 104 isolated human primary basophils
from low ( ≤ 32 kU/L) and high serum IgE donors ( > 32
kU/L) were incubated overnight in complete RPMI
medium in the presence or absence of bi53_79 (5 µM). IgE
removal was determined by ﬂow cytometry. The cells
were incubated in medium alone and resensitized or
saturated with Sus11-IgE. Basophil survival was mon-
itored with Annexin V and popidium iodide (PI) staining
and measured every 24 h. Viable cells were identiﬁed as
Annexin V/PI double negative cells.
A total of 1 × 105 cells from three different donors were
treated under the same conditions as described before to
perform western blot analysis. Proteins from every indi-
vidual donor were precipitated using 10% trichloroacetic
acid, pooled and separated on a NuPAGE 12% Bis-Tris
gels (Thermo Fisher) and transferred to a polyvinylidene
diﬂuoride membrane (Invitrogen, USA).
In vivo basophil quantiﬁcation
Dextran-sedimented supernatants from voluntary blood
donors were used for Percoll density centrifugation. The
basophil cell layer was collected and cells were stained
with anti-CD123 and anti-CD193 antibodies. Addition of
CountBright beads (LifeTechnologies, Carlsbad, USA)
allowed us to quantify the basophil (CD123+, CD193+)
cell number by ﬂow cytometry.
Blood from huFcεRIαtg and huFcεRIα−/− mice was
collected to determine the effect of receptor expression on
the absolute cell number. Basophils were identiﬁed as
CD49b+, CD200R3+, and CD4− cells using anti-murine
CD49b (eBioscience, Santa Clara, USA), anti-murine
CD200R3 (AbD Serotec, Hercules, USA), and anti-
murine CD4 (Biolegend, San Diego, USA). Data from
ﬂow cytometric measurement were further processed
using the FLOWJO software (TreeStar Inc., USA) and
normalized to total cell number per ml blood.
IL-3 induced upregulation of FcεRI
A total of 2.5 × 104 isolated human basophils were
incubated 24 h. The cells were cultured in presence and
absence of IL-3, IL-5, GM-CSF, and recombinant IL-3
receptor to block IL-3 binding to CD123. In addition, IgE
was removed from the cells o/n with bi53_79 and incu-
bated with or without Sus11-IgE (100 nM) and IL-3, IL-5,
GM-CSF, and recombinant IL-3. FcεRI expression and
receptor-bound IgE was monitored every 6 h with Flow
cytometry, as previously described. Results were normal-
ized to the geometric mean ﬂuorescence measured at T0
untreated. As the signal for the FcεRI receptor slightly
increase upon removal of the IgE, we suggest that the
staining antibody sterically interferes with receptor-bound
IgE. Results were thereby corrected by subtracting a mean
staining artifact (MSA). The artifact was deﬁned as the
difference in geometric mean between the untreated and
the bi53_79-treated group. The artifact of every mea-
surement was added and divided throughout the total
amount of measurements to generate the MSA.
Gene expression analysis
Human primary basophils were puriﬁed from whole
blood of six donors. Total RNA was isolated using the
RNeasy Mini kit (QIAgen) following manufacturer
instructions. The isolated amount of RNA was quantiﬁed
on a NanoDrop (Thermo Scientiﬁc) and tested for quality
using a bioanalyzer (Agilent). RNA fulﬁlling quality cri-
teria (RIN ≥ 6) of basophils from three different donors
were pooled and used for whole-genome array (Agilent
44k) measurements. Two individual arrays were per-
formed for each condition. Data were analyzed and mined
using the R project for statistical computing. Measured
spot intensities were normalized within and across arrays.
Values were log2-transformed. For several genes of
interest the relative log2 fold change (RLFC) between
medium treated cells and IL-3-treated cells was
calculated.
IL-3 upregulated FcεRI functionally activates basophils
Puriﬁed human blood basophils were seeded at 2.5 × 104
cells per well in medium in the presence and absence of
IL-3 for 18 h. The cells were then sensitized with NIP-
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speciﬁc JW8-IgE for 30min at 37 °C and washed twice
with 150 µl of PBS. For activation experiments, sensitized
cells were challenged with NIP-(7)-BSA (0.01-100 nM)
from Biosearch Technology (Petaluma, USA) or anti-
FcεRI from Bühlmann Laboratories for 25 min at 37 °C.
Basophil activation was determined by measuring surface
expression of basophil activation marker CD63 with
FlowCAST from Bühlmann Laboratories. IL-3-mediated
FcεRI upregulation correlation was performed comparing
initial FcεRI level with IL-3-treated FcεRI level. Total
surface IgE upon endogenous JW8-IgE sensitization of IL-
3- and non-IL-3-treated basophils was compared.
Generation of huFcεRIαtg BMMCs
Femors and tibiae of a huFcεRIαtg mouse were ﬂushed
with complete RPMI medium. The isolated bone marrow
was ﬁltered through a 70 μm cell strainer. Subsequently,
the cells were washed, resuspended in 25ml BMMC
culture medium (complete RPMI supplemented with
sodium pyruvate, L-glutamine, non-essential amino acids,
β-mercaptoethanol and recombinant murine IL-3) and
seeded in a T75 ﬂask. The cells were cultured for 4 weeks
at 37 °C, 5% CO2 and medium was changed twice a week.
Statistics
Statistical analysis was carried out with Prism 6.0 soft-
ware (GraphPad Software, La Jolla, Calif). All data are
shown as means ± SEM. Comparisons between different
treatments were analyzed by using Student’s t-test or one-
way analysis of variance. P values of < 0.05 were con-
sidered statistically signiﬁcant.
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